Biomark Capital Management’s Juno Therapeutics, Inc. JUNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-1,864,174
| Closed | -$85.2M | – | 3 |
|
|
2017
Q4 | $85.2M | Hold |
1,864,174
| – | – | 94.86% | 1 |
|
|
2017
Q3 | $83.6M | Hold |
1,864,174
| – | – | 94.97% | 1 |
|
|
2017
Q2 | $55.7M | Sell |
1,864,174
-304,427
| -14% | -$9.1M | 91.25% | 1 |
|
|
2017
Q1 | $48.1M | Hold |
2,168,601
| – | – | 87.21% | 1 |
|
|
2016
Q4 | $40.9M | Hold |
2,168,601
| – | – | 84.62% | 1 |
|
|
2016
Q3 | $65.1M | Sell |
2,168,601
-37,325
| -2% | -$1.12M | 86.12% | 1 |
|
|
2016
Q2 | $68.5M | Buy |
2,205,926
+603,364
| +38% | +$18.7M | 87.91% | 1 |
|
|
2016
Q1 | $61M | Hold |
1,602,562
| – | – | 83.87% | 1 |
|
|
2015
Q4 | $70.5M | Buy |
+1,602,562
| New | +$70.5M | 85.76% | 1 |
|